Genesis Geonomics Ready For Commercialization
By Scott A.Sumner
Thunder Bay Business
Bob Thayer of Genesis Genomics is very excited about the future of the company he founded. These are very exciting times at Genesis Genomics he noted while introducing Bob Poulter, the new President and CEO of the company. Poulter is a Thunder Bay native who graduated from LU in the B. Comm program before working for the Royal Bank for 10
years in Ottawa and Toronto. He then went overseas with Anderson Consulting in Malaysia and to IBM in Thailand and Singapore.

“ My skill is in being able to commercialize products that will generate significant revenues. Our goal in the shorter term is to leverage the product set we have and sign some licensing deals with significant players. The Skin Physical should happen first with the Biopsy Plus in 12 months,” noted Bob Poulter. “ We are seeing acceptance on DNA care side as well. The skin physical we are very excited about and all our products are well protected worldwide. As you generate revenues you need more admin staff and then will do more RD with the new revenues.”
“ The breadth and scope of our deals working on Skin Physical are huge. We can’t reveal all today but we will announce them as they happen. This is another milestone at Genesis Geonomics over our 6 year period and that is commercialization. Our products are near term close to agreements and contracts in the next 6 to 9 months,” noted Bob Thayer. “ The growth of the company has exceeded my skill set and at this period of time it is no time for me to learn on the job. So we were very fortunate to have Bob Poulter to provide the skill set from
strategic planning to financial planning to take this company into commercialization. That is what we need at this period. This is a very timely appointment.”
“ It is truly exciting to be in my home town for the first time 1994 to take this company to it’s next level of growth. The Skin Test is a very consumer friendly test. The DNA Care side of business is currently commercialized in UK and Europe. The Biopsy Plus test of the
Prostate undertaken in Maryland validated our marketing ,” noted Poulter. “ We have new strong board members in Greg Hines, Harry Smart and Michael Foul. One of the things is to go public with lots of financial experience which will strengthen us.”







